American Medical Women’s Association Position Statement on Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform
Journal of Women's Health · 01.09.2026 · 35 (9) · 809-812
DOI: 10.1177/15409996261449999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Women's Health, online erschienen am 08.05.2026. Verfasst von Rhea Manohar und 10 weiteren Autor:innen. Beteiligte Einrichtung: St. George University School of Medicine, St. George, Grenada. Hauptthemen laut MEDLINE: Poverty, Menstrual Hygiene Products, Insurance Coverage, Health Care Reform. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
One in four persons with a uterus is unable to afford menstrual products, with even higher prevalence among low-income populations, an unmet need that contributes to preventable infections, missed school and work, and persistent health inequities. Despite the essential role of menstrual products in basic health and hygiene, many public health coverage programs across the United States, including Medicaid and other assistance programs, continue to exclude items such as pads and tampons. This gap disproportionately harms individuals who already face significant economic and health disparities. Although Flexible Spending Accounts and Health Savings Accounts now permit the use of funds for menstrual products, these mechanisms primarily benefit individuals with stable employment and disposable income, leaving the most vulnerable populations unprotected. Continued exclusion by insurance and assistance programs imposes an unnecessary financial and health burden and undermines dignity and well-being. Federal and state policymakers, including Congress, the Centers for Medicare & Medicaid Services, and state Medicaid agencies, have clear authority to address this inequity by expanding definitions of “durable medical equipment” and “hygiene supplies” to explicitly include menstrual products and by removing administrative barriers to coverage. The American Medical Women’s Association calls for federal action to classify menstrual products as essential health services under Medicaid and other public assistance programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St. George University School of Medicine, St. George, Grenada.
- George Washington University Milken School of Public Health, Washington, District of Columbia, USA.
- Department of Population Health, Division of Family Medicine, The University of Texas at Austin Dell Medical School, San Antonio, Texas, USA.
- Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, USA.
- University of Minnesota, Minneapolis, Minnesota, USA.
- Russell Regional Hospital, Russell, Kansas, USA.
ORCID-Profile: Rhea Manohar, Meghan Etsey, Leah Liszak
Zitieren
APA
Manohar, R., Etsey, M., Liszak, L., Johnson, M., Patel, V. J., Patel, D., Marshall, A. L., Clark, B., Thachil, R., Gebhard, R., & AMWA Gender Equity Task Force (2026). American Medical Women’s Association Position Statement on Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform. Journal of Women's Health, 35(9), 809-812. https://doi.org/10.1177/15409996261449999
Vancouver
Manohar R, Etsey M, Liszak L, Johnson M, Patel VJ, Patel D, et al. American Medical Women’s Association Position Statement on Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform. Journal of Women's Health. 2026;35(9):809-812. doi:10.1177/15409996261449999
BibTeX
@article{Manohar2026,
author = {Manohar, Rhea and Etsey, Meghan and Liszak, Leah and Johnson, Mallory and Patel, Vaishnavi J and Patel, Devki and Marshall, Ariela L and Clark, Brianna and Thachil, Rosy and Gebhard, Roberta and AMWA Gender Equity Task Force, AMWA Gender Equity Task Force},
title = {American Medical Women’s Association Position Statement on Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform},
journal = {Journal of Women's Health},
year = {2026},
volume = {35},
number = {9},
pages = {809--812},
doi = {10.1177/15409996261449999}
}
EUVIMED